FRIDAY, Feb. 21, 2025 — Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a]) production, leads to a significant and sustained reduction in oxidized phospholipids (OxPL) on apolipoprotein B (apoB), according to a study published…Original Article
Olpasiran Leads to Significant Reduction in Oxidized Phospholipids
FRIDAY, Feb. 21, 2025 — Olpasiran, a small interfering RNA, which blocks lipoprotein(a) (Lp[a]) production, leads to a significant and sustained reduction in oxidized phospholipids (OxPL) on apolipoprotein B (apoB), according to a study published…
